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1. Introduction 
Extended-focus Optical Coherence Microscopy (xf-OCM) 
offers new roads for in-vitro as well in-vivo imaging in life 
sciences and medicine. We show the latest achievements based 
on this imaging modality with new applications for diabetes and 
Alzheimer’s disease research. 
 
2. Results and outlook 
In diabetes research a quantitative label-free imaging of islets of 
Langerhans is of high importance (see Fig. 1). xf-OCM 
circumvents the compromise between lateral resolution and 
depth of field by us of a Bessel-like illumination beam. The 
high sensitivity and parallel depth profiling of Fourier domain 
optical coherence tomography are preserved, and combined 
with a high isotropic resolution of 1.5 - 2 μm. A semi-automatic 
islet detection algorithm allows to measure in vitro and vivo 
islet size, position, contrast and homogeneity. Finally, xfOCM 
was used to assess the murine pancreas in situ and in vivo, 
visualizing pancreatic lobules, ducts, blood vessels and 
individual islets of Langerhans. 
As a next field of application, we present xf-OCM as an 
instrument for label-free investigation of the pathology of 
Alzheimer’s disease (AD) in a live mouse model. Both 
structural imaging of cerebral amyloid-β plaques (see Fig. 2), a 
hallmark of AD, and high-resolution functional imaging of the 
brain’s vascular network are demonstrated. Finally, a strategy to 
perform label-free longitudinal studies on the mouse brain using 
xfOCM is shown.  
Recently we upgraded the xf-OCM principle to darkfield 
Optical Coherence Microscopy (df-OCM) to provide further 
contrast enhancement applied to cell imaging (see Fig. 3). The 
darkfield effect suppresses direct reflection to a large extent, 
while keeping the benefits of fast imaging speed and high 
sensitivity of detection in the Fourier domain.  
Finally, we show that tissue, cell and sub-cellular structures can 
all be visualized based on these coherent imaging methods and therefore provide a variety of 
information with high spatial and temporal resolution. Across these different examples, we 
intend to provide new applications and innovative imaging technologies. 
Fig.1 Islets of Langerhans 
Fig. 2 Amyloid plaques  
Fig. 3 Neuron  
